Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001829126-25-000544
Filing Date
2025-01-29
Accepted
2025-01-29 17:26:11
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 ownership.html 5  
1 FORM 5 ownership.xml 5 5435
  Complete submission text file 0001829126-25-000544.txt   6883
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Issuer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 4545 HARRIS TRAIL NW ATLANTA GA 30327
Business Address
Owens David (Reporting) CIK: 0001916664 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-41507 | Film No.: 25570413